Abstract:In silico modeling of blood-brain barrier (BBB) permeability plays an important role in early discovery of central nervous system (CNS) drugs due to its high-throughput and cost-effectiveness. Natural products (NP) have demonstrated considerable therapeutic efficacy against several CNS diseases. However, BBB permeation property of NP is scarcely evaluated both experimentally and computationally. It is well accepted that significant difference in chemical spaces exists between NP and synthetic drugs, which calls into doubt on suitability of available synthetic chemical based BBB permeability models for the evaluation of NP. Herein poor discriminative performance on BBB permeability of NP are first confirmed using internal constructed and previously published drug-derived computational models, which warrants the need for NP-oriented modeling. Then a quantitative structure property relationship (QSPR) study on a NP dataset was carried out using four different machine learning methods including support vector machine, random forest, Naive Bayes and probabilistic neural network with 67 selected features. The final consensus model was obtained with approximate 90% overall accuracy for the cross-validation study, which is further taken to predict passive BBB permeability of a large dataset consisting of over 10,000 compounds from traditional Chinese medicine (TCM). For 32 selected TCM molecules, their predicted BBB permeability were evaluated by in vitro parallel artificial membrane permeability assay and overall accuracy for in vitro experimental validation is around 81%. Interestingly, our in silico model successfully predicted different BBB permeation potentials of parent molecules and their known in vivo metabolites. Finally, we found that the lipophilicity, the number of hydrogen bonds and molecular polarity were important molecular determinants for BBB permeability of NP. Our results suggest that the consensus model proposed in current work is a reliable tool for prioritizing potential CNS active NP across the BBB, which would accelerate their development and provide more understanding on their mechanisms, especially those with pharmacologically active metabolites. (C) 2017 Elsevier Inc. All rights reserved.

Recent Advances On In Silico Adme Modeling

In silico ADME-Tox modeling: progress and prospects

Advances in Computationally Modeling Human Oral Bioavailability.

Structure-ADME relationship: still a long way to go?

Analyzing the metabolic fate of oral administration drugs: A review and state-of-the-art roadmap.

The Trends and Future Prospective of In Silico Models from the Viewpoint of ADME Evaluation in Drug Discovery

Structure – ADME Relationship: Still a Long Way to Go?

Recent advances in computational prediction of drug absorption and permeability in drug discovery.

In Silico Modeling on ADME Properties of Natural Products: Classification Models for Blood-Brain Barrier Permeability, Its Application to Traditional Chinese Medicine and in Vitro Experimental Validation

Recent developments of in silico predictions of oral bioavailability.

Predicting ADME properties in silico: methods and models

In silico ADME/tox comes of age: twenty years later

Recent Progresses in the Exploration of Machine Learning Methods As In-Silico ADME Prediction Tools

Current status and future directions of high-throughput ADME screening in drug discovery

Open access in silico tools to predict the ADMET profiling of drug candidates

Role of in vitro two-dimensional (2D) and three-dimensional (3D) cell culture systems for ADME-Tox screening in drug discovery and development: a comprehensive review

Current development of integrated web servers for preclinical safety and pharmacokinetics assessments in drug development

Polymer membrane and cell models for drug discovery.

Recent Advances in Omics, Computational Models, and Advanced Screening Methods for Drug Safety and Efficacy

Validating ADME QSAR Models Using Marketed Drugs

ADME evaluation in drug discovery. 7. Prediction of oral absorption by correlation and classification.